 Drug Hypersensitivity
"Drug Hypersensitivity" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Immunologically mediated adverse reactions to medicinal substances used legally or illegally.
| Descriptor ID |
D004342
|
| MeSH Number(s) |
C20.543.206
|
| Concept/Terms |
Drug Hypersensitivity- Drug Hypersensitivity
- Drug Hypersensitivities
- Hypersensitivities, Drug
- Drug Allergy
- Allergies, Drug
- Drug Allergies
- Hypersensitivity, Drug
- Allergy, Drug
|
Below are MeSH descriptors whose meaning is more general than "Drug Hypersensitivity".
Below are MeSH descriptors whose meaning is more specific than "Drug Hypersensitivity".
This graph shows the total number of publications written about "Drug Hypersensitivity" by people in this website by year, and whether "Drug Hypersensitivity" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1993 | 1 | 0 | 1 | | 1994 | 2 | 1 | 3 | | 1995 | 1 | 0 | 1 | | 1998 | 1 | 0 | 1 | | 2003 | 1 | 0 | 1 | | 2004 | 2 | 1 | 3 | | 2005 | 0 | 1 | 1 | | 2008 | 3 | 0 | 3 | | 2013 | 1 | 1 | 2 | | 2021 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Drug Hypersensitivity" by people in Profiles.
-
Murphy KR, Patel NC, Ein D, Hudelson M, Kodoth S, Marshall GD, Parikh P, Blaiss MS. Insights from American College of Allergy, Asthma, and Immunology COVID-19 Vaccine Task Force: Allergic Reactions to mRNA SARS-CoV-2 Vaccines. Ann Allergy Asthma Immunol. 2021 Apr; 126(4):319-320.
-
Fantasia HC. Updated treatment guidelines for gonorrhea infections. Nurs Womens Health. 2013 Jun-Jul; 17(3):231-5.
-
Rhyee SH, Bienia-Kenton L, Collins A. Allergies to analgesic medications in ED patients. Am J Emerg Med. 2013 Feb; 31(2):431-2.
-
Paltiel M, Gober LM, Deng A, Mikdashi J, Alexeeva I, Saini SS, Gaspari AA. Immediate type I hypersensitivity response implicated in worsening injection site reactions to adalimumab. Arch Dermatol. 2008 Sep; 144(9):1190-4.
-
Hughes S, Hughes A, Brothers C, Spreen W, Thorborn D. PREDICT-1 (CNA106030): the first powered, prospective trial of pharmacogenetic screening to reduce drug adverse events. Pharm Stat. 2008 Apr-Jun; 7(2):121-9.
-
Mallal S, Phillips E, Carosi G, Molina JM, Workman C, Tomazic J, Jägel-Guedes E, Rugina S, Kozyrev O, Cid JF, Hay P, Nolan D, Hughes S, Hughes A, Ryan S, Fitch N, Thorborn D, Benbow A. HLA-B*5701 screening for hypersensitivity to abacavir. N Engl J Med. 2008 Feb 7; 358(6):568-79.
-
Brennan DD, Farrelly C, Cooney R, Norris S, McEniff N. Abdominal rash after transarterial chemoembolization via the right inferior phrenic artery. J Vasc Interv Radiol. 2005 Sep; 16(9):1269.
-
Henneman EA, Gawlinski A. A "near-miss" model for describing the nurse's role in the recovery of medical errors. J Prof Nurs. 2004 May-Jun; 20(3):196-201.
-
Gammon D, Bhargava P, McCormick MJ. Hypersensitivity reactions to oxaliplatin and the application of a desensitization protocol. Oncologist. 2004; 9(5):546-9.
-
Bhargava P, Gammon D, McCormick MJ. Hypersensitivity and idiosyncratic reactions to oxaliplatin. Cancer. 2004 Jan 1; 100(1):211-2.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|